PBM solution that extracts
autologous exosomes from the patient’s own pure blood and
activates 299.3 billion
autologous exosomes per 1 ml.
Utilizing Photo-Thermal
BioModulation (PBM) technology
with five types of light and
temperature, Metacell uses
the patient’s own plasma to
extract and activate autologous
exosomes, ensuring
biocompatible results.
PBM solution that extracts autologous exosomes from the patient’s
own pure blood and activates 299.3 billion autologous exosomes per 1 ml.
Utilizing Photo-Thermal BioModulation (PBM) technology with
five types of light and temperature,
Metacell uses the patient’s own plasma to extract and
activate autologous exosomes, ensuring biocompatible results.
Compared to conventional PRP methods, when platelets are stimulated by photothermal energy, growth factors are activated three times more.
This process occurs in a more physiological manner.
When mitochondria are exposed to light of an appropriate wavelength,
large complexes within the cellular respiratory chain receive energy and
undergo changes in their electron states.
To restore energy balance, mitochondria regulate the trans-membrane proton gradient,
and this process can lead to enhanced ATP activation.
Light stimulation helps reduce the concentration of pro-inflammatory cytokines in plasma,
guides physiological properties such as pH in a more stable direction,
and promotes the secretion of plasma growth factors.
It can also support reactions related to blood cell production in PRP.
Prepares platelets to act more actively and effectively, while being compatible with
various types of plasma and commercially available PRP kits.
Rather than simply concentrating platelets,
it focuses on activating them through a specialized photothermal stimulation–based
conditioning protocol.
Heat-treated plasma provides higher patient satisfaction compared to
conventional PRP due to changes in density.
PRP treated with Metacell induces effective and natural results.